Literature DB >> 22583578

Risk-prediction tool for identifying hospitalized children with a predisposition for development of venous thromboembolism: Peds-Clot clinical Decision Rule.

A A Sharathkumar1, A Mahajerin, L Heidt, K Doerfer, M Heiny, T Vik, R Fallon, A Rademaker.   

Abstract

BACKGROUND: The prevalence of VTE is increasing in tertiary pediatric hospitals. Identification of high-risk populations using uniform criteria is required to develop evidence-based VTE prevention guidelines.
OBJECTIVE: To develop a VTE risk prediction rule, the Peds-Clot clinical Decision Rule (PCDR), to identify high-risk children who were at increased risk of developing VTE.
METHODS: This retrospective case-control study developed the PCDR using a derivation cohort (173 cases, 346 controls) and validated it on a separate validation cohort (100 cases, 100 controls). A uniform data collection strategy was applied to derive both the samples. Conditional logistic regression analyses were used to develop a risk-prediction model. Each significant predictor was assigned a score based on its beta coefficient and the PCDR was developed. ROC curves were derived to test the performance of the PCDR.
RESULTS: Characteristics of derivation and validation cohorts were comparable. Six risk factors (positive blood stream infection, central venous catheter, direct admission to ICU/NICU, hospitalization for ≥ 7 days, immobilization for > 72 h, and use of birth control pills) formed the final risk prediction model (risk score range, 0.5-9.5). A risk score of 3 or more identified high-risk children at a sensitivity of 70% and specificity of 80% and AUC of 0.852 (95% confidence interval, 0.814-0.890). The application of a risk score to the validation sample showed sensitivity 57% and specificity 88% and an AUC of 0.875 (95% confidence interval, 0.82-0.924).
CONCLUSION: Incorporation of the PCDR in routine clinical care can be an attractive strategy to identify high-risk hospitalized children with a predisposition for VTE. The clinical utility of the PCDR needs validation in prospective studies.
© 2012 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Year:  2012        PMID: 22583578     DOI: 10.1111/j.1538-7836.2012.04779.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  13 in total

Review 1.  Hospital-associated venous thromboembolism in pediatrics: a systematic review and meta-analysis of risk factors and risk-assessment models.

Authors:  Arash Mahajerin; Brian R Branchford; Ernest K Amankwah; Leslie Raffini; Elizabeth Chalmers; C Heleen van Ommen; Neil A Goldenberg
Journal:  Haematologica       Date:  2015-05-22       Impact factor: 9.941

2.  Development of a new risk score for hospital-associated venous thromboembolism in noncritically ill children: findings from a large single-institutional case-control study.

Authors:  Christie M Atchison; Shilpa Arlikar; Ernest Amankwah; Irmel Ayala; Laurie Barrett; Brian R Branchford; Michael Streiff; Clifford Takemoto; Neil A Goldenberg
Journal:  J Pediatr       Date:  2014-07-23       Impact factor: 4.406

3.  Epidemiology and outcomes of clinically unsuspected venous thromboembolism in children: A systematic review.

Authors:  Anjali A Sharathkumar; Tina Biss; Ketan Kulkarni; Sanjay Ahuja; Matt Regan; Christoph Male; Shoshana Revel-Vilk
Journal:  J Thromb Haemost       Date:  2020-04-15       Impact factor: 5.824

4.  A New Risk Assessment Model for Hospital-Acquired Venous Thromboembolism in Critically Ill Children: A Report From the Children's Hospital-Acquired Thrombosis Consortium.

Authors:  Julie Jaffray; Arash Mahajerin; Brian Branchford; Anh Thy H Nguyen; E Vincent S Faustino; Michael Silvey; Stacy E Croteau; John H Fargo; James D Cooper; Nihal Bakeer; Neil A Zakai; Amy Stillings; Emily Krava; Ernest K Amankwah; Guy Young; Neil A Goldenberg
Journal:  Pediatr Crit Care Med       Date:  2022-01-01       Impact factor: 3.971

5.  Increasing rate of pulmonary embolism diagnosed in hospitalized children in the United States from 2001 to 2014.

Authors:  Shannon L Carpenter; Troy Richardson; Matt Hall
Journal:  Blood Adv       Date:  2018-06-26

6.  A Real-time Risk-Prediction Model for Pediatric Venous Thromboembolic Events.

Authors:  Shannon C Walker; C Buddy Creech; Henry J Domenico; Benjamin French; Daniel W Byrne; Allison P Wheeler
Journal:  Pediatrics       Date:  2021-05-19       Impact factor: 9.703

Review 7.  Epidemiology and Risk Assessment of Pediatric Venous Thromboembolism.

Authors:  Arash Mahajerin; Stacy E Croteau
Journal:  Front Pediatr       Date:  2017-04-10       Impact factor: 3.418

8.  Coagulation disorders in Duchenne muscular dystrophy? Results of a registry-based online survey.

Authors:  David C Schorling; Cornelia K Müller; Astrid Pechmann; Sabine Borell; Thorsten Langer; Simone Thiele; Maggie C Walter; Barbara Zieger; Janbernd Kirschner
Journal:  Acta Myol       Date:  2020-03-01

9.  Association of Obesity and Pediatric Venous Thromboembolism.

Authors:  Elizabeth E Halvorson; Sean E Ervin; Thomas B Russell; Joseph A Skelton; Stephen Davis; John Spangler
Journal:  Hosp Pediatr       Date:  2015-01-01

Review 10.  Pediatric Hospital Acquired Venous Thromboembolism.

Authors:  Char M Witmer; Clifford M Takemoto
Journal:  Front Pediatr       Date:  2017-09-19       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.